Priority Review Vouchers One Step Closer, But Congress Must Act Again
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA guidance on incentive for neglected tropical disease research clarifies some key questions—but also stresses need for appropriation authority to make program work.